These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3780540

  • 1. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
    Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER.
    Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
    [Abstract] [Full Text] [Related]

  • 2. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
    Safadi FF, Hermey DC, Popoff SN, Seifert MF.
    Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
    [Abstract] [Full Text] [Related]

  • 3. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
    Bikle DD, Halloran BP, McGalliard-Cone C, Morey-Holton E.
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
    [Abstract] [Full Text] [Related]

  • 4. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
    Bagi CM, Miller SC.
    J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
    [Abstract] [Full Text] [Related]

  • 5. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.
    Halloran BP, Bikle DD, Levens MJ, Castro ME, Globus RK, Holton E.
    J Clin Invest; 1986 Sep; 78(3):622-8. PubMed ID: 3489007
    [Abstract] [Full Text] [Related]

  • 6. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ, Travers R.
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [Abstract] [Full Text] [Related]

  • 7. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ, Qi H, Crawford DT, Simmons HA, Xu G, Li M, Plum L, Clagett-Dame M, DeLuca HF, Thompson DD, Brown TA.
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [Abstract] [Full Text] [Related]

  • 8. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG.
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [Abstract] [Full Text] [Related]

  • 9. Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow.
    Erben RG, Scutt AM, Miao D, Kollenkirchen U, Haberey M.
    Endocrinology; 1997 Nov; 138(11):4629-35. PubMed ID: 9348188
    [Abstract] [Full Text] [Related]

  • 10. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
    Lemay J, Gascon-Barré M.
    Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
    [Abstract] [Full Text] [Related]

  • 11. Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats.
    Verhaeghe J, Suiker AM, Van Bree R, Van Herck E, Jans I, Visser WJ, Thomasset M, Allewaert K, Bouillon R.
    Am J Physiol; 1993 Aug; 265(2 Pt 1):E215-23. PubMed ID: 8368291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
    Matsumoto T, Igarashi C, Takeuchi Y, Harada S, Kikuchi T, Yamato H, Ogata E.
    Bone; 1991 Aug; 12(1):27-32. PubMed ID: 2054233
    [Abstract] [Full Text] [Related]

  • 14. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH.
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.
    Oelzner P, Petrow PK, Wolf G, Bräuer R.
    BMC Musculoskelet Disord; 2014 Oct 14; 15():345. PubMed ID: 25315028
    [Abstract] [Full Text] [Related]

  • 17. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
    Blazhevich NV, Sergeev IN, Arkhapchev IuP, Isaeva VA, Spirichev VB.
    Vopr Med Khim; 1982 Oct 14; 28(6):98-105. PubMed ID: 6297167
    [Abstract] [Full Text] [Related]

  • 18. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
    Hinek A, Poole AR.
    J Bone Miner Res; 1988 Aug 14; 3(4):421-9. PubMed ID: 3265578
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
    Erben RG, Bromm S, Stangassinger M.
    Endocrinology; 1998 Oct 14; 139(10):4319-28. PubMed ID: 9751515
    [Abstract] [Full Text] [Related]

  • 20. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 Oct 14; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.